Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-1995 | 01-1995 | 10-1994 | 07-1994 | 04-1994 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 6,549 | 5,545 | 5,588 | 4,548 | 4,281 |
| TOTAL | $6,549 | $5,545 | $5,588 | $4,548 | $4,281 |
| Non-Current Assets | |||||
| PPE Net | 21,350 | N/A | 15,248 | 13,473 | 11,050 |
| Other Non-Current Assets | 4,205 | 4,233 | 4,143 | 4,329 | 4,394 |
| TOTAL | $25,555 | $4,233 | $19,391 | $17,802 | $15,444 |
| Total Assets | $32,104 | $9,778 | $24,979 | $22,350 | $19,725 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 23,040 | 0 | 11,564 | 0 | 0 |
| Accounts payable and accrued liabilities | 9,850 | 7,884 | 7,731 | 8,723 | 6,670 |
| Accrued Expenses | 7,048 | 6,106 | 7,207 | 4,196 | 3,772 |
| TOTAL | $39,938 | $33,261 | $26,502 | $22,611 | $17,345 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 639 | 669 | 699 | 728 | 757 |
| TOTAL | $2,004 | $2,035 | $2,067 | $2,232 | $2,269 |
| Total Liabilities | $41,942 | $35,296 | $28,569 | $24,843 | $19,614 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -6,691 | -6,844 | -7,108 | -7,300 | -7,397 |
| TOTAL | $5,085 | $4,892 | $16,620 | $16,428 | $16,331 |
| Total Liabilities And Equity | $47,027 | $40,188 | $45,189 | $41,271 | $35,945 |